These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan. Liu RC Am J Cardiovasc Drugs; 2018 Dec; 18(6):473-482. PubMed ID: 29850980 [TBL] [Abstract][Full Text] [Related]
5. Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure. Iovanovici DC; Bungau SG; Vesa CM; Moisi M; Babes EE; Tit DM; Horvath T; Behl T; Rus M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232632 [TBL] [Abstract][Full Text] [Related]
6. Sacubitril/Valsartan Initiation Among Veterans Who Are Renin-Angiotensin-Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction. Mohanty AF; Levitan EB; King JB; Dodson JA; Vardeny O; Cook J; Herrick JS; He T; Patterson OV; Alba PR; Russo PA; Obi EN; Choi ME; Fang JC; Bress AP J Am Heart Assoc; 2021 Oct; 10(20):e020474. PubMed ID: 34612065 [TBL] [Abstract][Full Text] [Related]
7. Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan: Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis. Rohde LE; Claggett BL; Wolsk E; Packer M; Zile M; Swedberg K; Rouleau J; Pfeffer MA; Desai AS; Lund LH; Kober L; Anand I; Merkely B; Senni M; Shi V; Rizkala A; Lefkowitz M; McMurray JJV; Solomon SD Circ Heart Fail; 2021 Mar; 14(3):e008052. PubMed ID: 33706551 [TBL] [Abstract][Full Text] [Related]
8. Current and emerging drug targets in heart failure treatment. Ghionzoli N; Gentile F; Del Franco AM; Castiglione V; Aimo A; Giannoni A; Burchielli S; Cameli M; Emdin M; Vergaro G Heart Fail Rev; 2022 Jul; 27(4):1119-1136. PubMed ID: 34273070 [TBL] [Abstract][Full Text] [Related]
9. Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure. Marques da Silva P; Aguiar C Rev Port Cardiol; 2017 Sep; 36(9):655-668. PubMed ID: 28844335 [TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology. Perrone-Filardi P; Paolillo S; Agostoni P; Basile C; Basso C; Barillà F; Correale M; Curcio A; Mancone M; Merlo M; Metra M; Muscoli S; Nodari S; Palazzuoli A; Pedrinelli R; Pontremoli R; Senni M; Volpe M; Indolfi C; Sinagra G Eur J Intern Med; 2022 Aug; 102():8-16. PubMed ID: 35469709 [TBL] [Abstract][Full Text] [Related]
11. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure. Solomon SD; Vaduganathan M; L Claggett B; Packer M; Zile M; Swedberg K; Rouleau J; A Pfeffer M; Desai A; Lund LH; Kober L; Anand I; Sweitzer N; Linssen G; Merkely B; Luis Arango J; Vinereanu D; Chen CH; Senni M; Sibulo A; Boytsov S; Shi V; Rizkala A; Lefkowitz M; McMurray JJV Circulation; 2020 Feb; 141(5):352-361. PubMed ID: 31736342 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients With Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection Fraction and Sex. Mitchell GF; Solomon SD; Shah AM; Claggett BL; Fang JC; Izzo J; Abbas CA; Desai AS; Circ Heart Fail; 2021 Mar; 14(3):e007891. PubMed ID: 33663237 [TBL] [Abstract][Full Text] [Related]
18. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction. Nguyen E; Weeda ER; White CM J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms and Models in Heart Failure: A Translational Approach. Mann DL; Felker GM Circ Res; 2021 May; 128(10):1435-1450. PubMed ID: 33983832 [TBL] [Abstract][Full Text] [Related]